Subscribe to RSS
DOI: 10.1055/s-0043-122881
The Beneficial Effects of Trimetazidine on Reperfusion–Induced Arrhythmia in Diabetic Rats
Publication History
received 06 August 2017
revised 22 October 2017
accepted 13 November 2017
Publication Date:
05 March 2018 (online)
![](https://www.thieme-connect.de/media/eced/201905/lookinside/thumbnails/08-2017-0301-dia_10-1055-s-0043-122881-1.jpg)
Abstract
Trimetazidine (TMZ), as an anti-ischemic drug, plays a critical role in protecting against cardiovascular complications induced by diabetes. This study was therefore aimed to evaluate the protective effects of TMZ on reperfusion-induced arrhythmias in the diabetic rats. Male Sprague-Dawley rats (250±20 g) were randomly assigned to four (n=8): control rats (C), alloxan induced diabetic rats (D), diabetic rats treated with TMZ (10 mg/kg, D+T10), diabetic rats treated with TMZ (30 mg/kg, D+T30). TMZ was treated orally once daily for 8 weeks. Diabetes was induced by a single intraperitoneal injection of alloxan (120 mg/kg). Ischemia-reperfusion (I/R) was carried out via 30 min of ischemia and following120-min reperfusion. The magnitude and score of arrhythmia, the left ventricular function, infarct size, lactate dehydrogenase (LDH), myocardial creatine kinase (CK-MB) and troponin (cTnI) were measured. The findings were evaluated by two-way repeated measures and one-way ANOVA followed by LSD post hoc test and Fisher's exact test for incidence percentage. The duration, incidence and score of arrhythmia (p<0.001), infarct size (p<0.01) were significantly increased, the cardiac contractility (±dp/dt), LDH, CK-MB (p<0.001) and cTnI (p<0.05) were significantly decreased in the diabetic rats in comparison with the control group. However, treatment with TMZ in the diabetic rats was significantly improved the duration (p<0.001), incidence and score of arrhythmia,±dp/dt LDH, CK-MB, cTnI (p<0.05) and infarct size (p<0.01) in comparison with the untreated diabetic group. The present study indicates anti-arrhythmic effect of TMZ in reducing arrhythmias induced by reperfusion in the diabetic rats.
-
References
- 1 Donahoe SM, Stewart GC, McCabe CH. et al. Diabetes and mortality following acute coronary syndromes. JAMA 2007; 298: 765-775
- 2 Ikizler M, Erkasap N, Dernek S. et al. Trimetazidine-induced enhancement of myocardial recovery during reperfusion: A comparative study in diabetic and non-diabetic rat hearts. Arch Med Res 2006; 37: 700-708
- 3 Norhammar A, Mellbin L, Cosentino F. Diabetes: Prevalence, prognosis and management of a potent cardiovascular risk factor. Eur J Prev Cardio 2017; 24: 52-60
- 4 Malmberg K, Ryden L. Myocardial infarction in patients with diabetes mellitus. Eur Heart J 1988; 9: 259-264
- 5 Stettler C, Bearth A, Allemann S. et al. QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: A 23-year follow-up. Diabetologia 2007; 50: 186-194
- 6 Sakakibara M, Hirashiki A, Cheng XW. et al. Association of diabetes mellitus with myocardial collagen accumulation and relaxation impairment in patients with dilated cardiomyopathy. Diabetes Res Clin Pract 2011; 92: 348-355
- 7 Ghaly HA, Boyle PM, Vigmond EJ. et al. Simulations of reduced conduction reserve in the diabetic rat heart: Response to uncoupling and reduced excitability. Ann Biomed Eng 2010; 38: 1415-1425
- 8 Nygren A, Olson ML, Chen KY. et al. Propagation of the cardiac impulse in the diabetic rat heart: Reduced conduction reserve. J Physiol 2007; 580: 543-560
- 9 Lin H, Ogawa K, Imanaga I. et al. Remodeling of connexin 43 in the diabetic rat heart. Mol Cell Biochem 2006; 290: 69-78
- 10 Stilli D, Lagrasta C, Berni R. et al. Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves changes in myocyte size, number and intercellular coupling. Basic Res Cardiol 2007; 102: 488-499
- 11 Penkoske PA, Sobel BE, Corr PB. Disparate electrophysiological alterations accompanying dysrhythmia due to coronary occlusion and reperfusion in the cat. Circulation 1978; 58: 1023-1035
- 12 Wu Y, Temple J, Zhang R. et al. Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy. Circulation 2002; 106: 1288-1293
- 13 Oyamada M, Tsujii E, Tanaka H. et al. Abnormalities in gap junctions and Ca2+ dynamics in cardiomyocytes at the border zone of myocardial infarcts. Cell Commun Adhes 2001; 8: 335-338
- 14 Barsotti A, Di Napoli P. Trimetazidine and cardioprotection during ischemia-reperfusion. Ital Heart J 2004; 5: 29S-36S
- 15 Liu YC, Li L, Su Q. et al. Trimetazidine pretreatment inhibits myocardial apoptosis and improves cardiac function in a Swine model of coronary microembolization. Cardiology 2015; 130: 130-136
- 16 Rosano GM, Vitale C, Sposato B. et al. Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study. Cardiovasc Diabetol 2003; 2: 16
- 17 Belardinelli R, Solenghi M, Volpe L. et al. Trimetazidine improves endothelial dysfunction in chronic heart failure: An antioxidant effect. Eur Heart J 2007; 28: 1102-1108
- 18 Xiang YL, He L, Xiao J. et al. Effect of trimetazidine treatment on the transient outward potassium current of the left ventricular myocytes of rats with streptozotocin-induced type 1 diabetes mellitus. Braz J Med Biol Res 2012; 45: 205-211
- 19 Weiss JN, Korge P, Honda HM. et al. Role of the mitochondrial permeability transition in myocardial disease. Circ Res 2003; 93: 292-301
- 20 Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion–a target for cardioprotection. Cardiovasc Res 2004; 61: 372-385
- 21 Baharvand B, Esmailidehaj M, Alihosaini J. et al. Prophylactic and therapeutic effects of oleuropein on reperfusion-induced arrhythmia in anesthetized rat. Iran Biomed J 2016; 20: 41-48
- 22 Curtis MJ, Walker MJ. Quantification of arrhythmias using scoring systems: An examination of seven scores in an in vivo model of regional myocardial ischaemia. Cardiovasc Res 1988; 22: 656-665
- 23 Liu Z, Chen JM, Huang H. et al. The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway. Metabolism 2016; 65: 122-130
- 24 Zhong Y, Zhong P, He S. et al. Trimetazidine protects cardiomyocytes against hypoxia/reoxygenation injury by promoting amp-activated protein kinase-dependent autophagic flux. J Cardiovasc Pharmacol 2017; 69: 389-397
- 25 Halestrap AP, Doran E, Gillespie JP. et al. Mitochondria and cell death. Biochem Soc Trans 2000; 28: 170-177
- 26 Niizuma K, Endo H, Chan PH. Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J Neurochem 2009; 109: 133-138
- 27 Aon MA, Cortassa S, Marban E. et al. Synchronized whole cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes. J Biol Chem 2003; 278: 44735-44744
- 28 Thummasorn S, Kumfu S, Chattipakorn S. et al. Granulocyte-colony stimulating factor attenuates mitochondrial dysfunction induced by oxidative stress in cardiac mitochondria. Mitochondrion 2011; 11: 457-466
- 29 Onay-Besikci A, Guner S, Arioglu E. et al. The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts. Can J Physiol Pharmacol 2007; 85: 527-535
- 30 Kantor PF, Lucien A, Kozak R. et al. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res 2000; 86: 580-588
- 31 Billman GE. Role of ATP sensitive potassium channel in extracellular potassium accumulation and cardiac arrhythmias during myocardial ischaemia. Cardiovasc Res 1994; 28: 762-769
- 32 Singh VP, Rubinstein J, Arvanitis DA. et al. Abnormal calcium cycling and cardiac arrhythmias associated with the human Ser96Ala genetic variant of histidine-rich calcium-binding protein. J Am Heart Assoc 2013; 2: e000460
- 33 Dumas F, Manzo-Silberman S, Fichet J. et al. Can early cardiac troponin I measurement help to predict recent coronary occlusion in out-of-hospital cardiac arrest survivors?. Crit Care Med 2012; 40: 1777-1784
- 34 Metzler B, Hammerer-Lercher A, Jehle J. et al. Plasma cardiac troponin T closely correlates with infarct size in a mouse model of acute myocardial infarction. Clin Chim Acta 2002; 325: 87-90
- 35 Chinda K, Sanit J, Chattipakorn S. et al. Dipeptidyl peptidase-4 inhibitor reduces infarct size and preserves cardiac function via mitochondrial protection in ischaemia-reperfusion rat heart. Diab Vasc Dis Res 2014; 11: 75-83